Press Releases
Ariana(R) Pharma and CTCLS sign Japanese distribution agreement for data analysis technology
Ariana Pharma, the premium provider of advanced, non-statistical clinical data and biomarker analytics technology across life science industries as well as the FDA, today announces...
Press Releases
TxCell announces publication of CATS1 study results for antigen-specific Treg therapy in Crohn¹s disease in Gastroenterology
TxCell SA, a biotechnology company developing cell-based immunotherapies for the treatment of severe chronic inflammatory diseases with high unmet medical need, announces today the...
Press Releases
Cytheris announces US Orphan Drug Designation for CYT107 for the treatment of Progressive Multifocal Leucoencephalopathy (PML)
Cytheris SA, a clinical-stage biopharmaceutical company focused on treating lymphopenia driven diseases, announces today that the US Food and Drug Administration (FDA) has granted an...
Press Releases
Domain Therapeutics enters into collaboration agreement with Ono in the field of GPCR-based drug discovery
Domain Therapeutics S.A. announced today that Domain Therapeutics and Ono Pharmaceutical Co., Ltd. (Osaka, Japan) signed a collaboration agreement focused on discovering small molecules...
Press Releases
Adocia is extending its intellectual property to new formulations of monoclonal antibodies
Adocia , a biotech company specialized in the formulation of therapeutic proteins for the treatment of diabetes and chronic wounds, announces today that it...
Press Releases
FDA Advisory Committee Recommends KYNAMRO™ for Homozygous Familial Hypercholesterolemia
Genzyme, a Sanofi company , and Isis Pharmaceuticals Inc. , announced today that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food...
Press Releases
FDA Advisory Committee Unanimously Recommends Approval of Gattex® (teduglutide) for Adults with Short Bowel Syndrome (SBS)
NPS Pharmaceuticals, Inc. , a biopharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, announced today that the U.S. Food and Drug...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.